Showing results (231-240 of 428) with videos related to

Sort By:
Pageof 43
Plos One|April 10, 2008
Oral high-dose atorvastatin treatment in relapsing-remitting multiple sclerosisFriedemann Paul, Sonia Waiczies, Jens Wuerfel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 21, 2016
Role of IL-17-producing lymphocytes in severity of multiple sclerosis upon natalizumab treatmentUlrike Bühler, Vinzenz Fleischer, Felix Luessi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 1, 2022
Association of obesity with disease outcome in multiple sclerosisIsabel Lutfullin, Maria Eveslage, Stefan Bittner, et al.
Journal of Neuroimmunology|March 17, 2004
Identification and functional characterization of a highly polymorphic region in the human TRAIL promoter in multiple sclerosisAlexandra Weber, Klaus-Peter Wandinger, Wolf Mueller, et al.
Nature Cell Biology|March 18, 2008
Sirt1 contributes critically to the redox-dependent fate of neural progenitorsTimour Prozorovski, Ulf Schulze-Topphoff, Robert Glumm, et al.
The Journal of Clinical Investigation|June 16, 2007
TRAIL limits excessive host immune responses in bacterial meningitisOlaf Hoffmann, Josef Priller, Timour Prozorovski, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 27, 2015
Cross-recognition of a myelin peptide by CD8+ T cells in the CNS is not sufficient to promote neuronal damageEva Reuter, René Gollan, Nadia Grohmann, et al.
Journal of Visualized Experiments : Jove|March 6, 2015
An ex vivo model of an oligodendrocyte-directed T-cell attack in acute brain slicesKerstin Göbel, Stefan Bittner, Manuela Cerina, et al.
The Journal of Biological Chemistry|April 1, 2008
TWIK-related acid-sensitive K+ channel 1 (TASK1) and TASK3 critically influence T lymphocyte effector functionsSven G Meuth, Stefan Bittner, Patrick Meuth, et al.
Pageof 43